🇺🇸 FDA
Pipeline program

Guselkumab

CHDR1806

Unknown small_molecule terminated

Quick answer

Guselkumab for Psoriasis Vulgaris is a Unknown program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Psoriasis Vulgaris
Phase
Unknown
Modality
small_molecule
Status
terminated

Clinical trials